Continuing Medical Education Information

 

AACE Endocrine University

Event start date: 02/20/2025
Credit claim deadline: 12/31/2025

 

Statement of Need

Endocrine University® is designed to provide a forum for endocrinology fellows -in-training to enhance their endocrine curriculum, particularly in diabetes, thyroid, bone, and new technology which has become essential to the practice of endocrinology.

 

Target Audience:

This program is intended for first year Endocrine Fellows-in-Training.

 

Learning Objectives

By the end of the meeting, participants will be able to:

  • Effectively utilize new skills and technology in diabetes and thyroid ultrasound.
  • Apply the most up-to-date guidelines and evidence-based practices for the diagnosis and treatment of diabetes and thyroid disease.
  • Integrate the latest evidence-based research for diagnosis and treatment of emerging areas of diabetes, thyroid, and bone related practice.

 

Accreditation and Designation Statements

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology (ACE) designates this other (live virtual) activity for a maximum of 16 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Commercial Support

This activity is supported by educational grants from the following:

  • Abbott Diabetes Care
  • Novartis
  • Novo Nordisk
  • Vertex Pharmaceuticals, Inc.
  • Corcept Therapeutics
  • Medtronic, Inc.
  • Immunovant
  • Insulet Corporation
  • Xeris Pharmaceuticals
  • Ultragenyx Pharmaceuticals
  • Recordati Rare Diseases